SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-012305
Filing Date
2023-04-10
Accepted
2023-04-10 16:40:31
Documents
21

Document Format Files

Seq Description Document Type Size
1 PRE 14A crsp-20230410.htm   iXBRL PRE 14A 4722951
2 GRAPHIC img168422979_0.jpg GRAPHIC 19505
3 GRAPHIC img168422979_1.jpg GRAPHIC 25755
4 GRAPHIC img168422979_2.jpg GRAPHIC 223937
5 GRAPHIC img168422979_3.jpg GRAPHIC 214445
6 GRAPHIC img168422979_4.jpg GRAPHIC 230442
7 GRAPHIC img168422979_5.jpg GRAPHIC 587237
8 GRAPHIC img168422979_6.jpg GRAPHIC 344661
  Complete submission text file 0000950170-23-012305.txt   10068906

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crsp-20230410_def.xml EX-101.DEF 6172
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20230410.xsd EX-101.SCH 5527
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20230410_pre.xml EX-101.PRE 7771
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20230410_lab.xml EX-101.LAB 12274
15 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20230410_htm.xml XML 569742
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37923 | Film No.: 23811559
SIC: 2836 Biological Products, (No Diagnostic Substances)